Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Genocea to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Ocular Therapeutix™ to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
Rosetta Genomics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Bio-Path Holdings to Present at the 2nd Annual Cantor Fitzgerald Healthcare Conference
-
Depomed to Present at the Cantor Fitzgerald Healthcare Conference
-
Intra-Cellular Therapies to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Karyopharm to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Aerie Pharmaceuticals to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Arrowhead Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Corbus Pharmaceuticals to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference on July 12, 2016
-
Strongbridge Biopharma plc Announces Presentation at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Spectrum Pharmaceuticals to Present Corporate Update at the Cantor Fitzgerald’s 2nd Annual Healthcare Conference on July 13th
-
AcelRx Pharmaceuticals to Present at Cantor Fitzgerald 2nd Annual Healthcare Conference
-
Concert Pharmaceuticals Announces Webcast at Cantor Fitzgerald Healthcare Conference
-
CytoSorbents to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
BioDelivery Sciences to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
miRagen Therapeutics to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference July 13, 2016
-
Verastem to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Zynerba Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
vTv Therapeutics to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Cidara Therapeutics to Present at the Cantor Fitzgerald Annual Healthcare Conference
-
Synthetic Biologics to Present at the 2nd Annual Cantor Fitzgerald Healthcare Conference
-
Fennec to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference in New York on July 13, 2016
-
/C O R R E C T I O N -- Trovagene, Inc./
-
Trovagene to Present at the 2nd Annual Cantor Fitzgerald Healthcare Conference
-
Corium to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Akebia to Present at the Cantor Fitzgerald Annual Healthcare Conference
-
Cytokinetics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
XOMA to Present at the Cantor Fitzgerald Healthcare Conference
-
Cambrex to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
NeuroDerm to Present at the Cantor Fitzgerald Healthcare Conference on July 13
-
Aclaris Therapeutics to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
Cerus to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference on July 13, 2016
-
Regulus to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Aimmune Therapeutics to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Alcobra Ltd. to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
Cara Therapeutics to Webcast Presentation at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Nabriva to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
ArQule to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference on July 12, 2016
-
Axsome Therapeutics to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
Mirna Therapeutics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Sunesis Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Radius Health to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
T2 Biosystems to Present at the Cantor Fitzgerald Healthcare Conference
-
Nicox to transfer Commercial Operations to new pan-European Ophthalmic Specialty Pharmaceutical Company led by GHO Capital
-
Vitae Pharmaceuticals (VTAE) Enters $40M ATM Offering
-
Veracyte to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Abeona Therapeutics to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Adamas Pharmaceuticals to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
ChemoCentryx to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference


